Weight-loss patients voice concerns as CVS Caremark drops Zepbound coverage for Wegovy, though exceptions may exist for those ...

Mounjaro – which competes in the market with Novo Nordisk's GLP-1 agonist Ozempic (semaglutide) – was 8% better than ...

Ozempic and Mounjaro are both very popular for weight loss at the minute, but there's one big difference between the two ...

GLP-1 drugs like semaglutide (Ozempic) and tirzepatide (Mounjaro) may shrink fat, but also crucial muscle mass, with little ...

While Ozempic is effective at treating type 2 diabetes and supporting weight loss, it can also come with side effects.

A new study reports that mice shed about 20% of their body weight and saw their breast cancer tumors decrease after getting ...

Powerful new medications such as Ozempic and Mounjaro, known as GLP-1 drugs are helping to win the war against obesity in ...

The Danish firm blamed the move to slash its guidance on intense competition from rivals and copycat drugs in the US.

GoodRx reports that insurance coverage for GLP-1 medications varies. It's more likely when prescribed for FDA-approved uses ...

New research shows that most people regain weight after stopping Ozempic and similar weight-loss drugs around the eight-week ...